Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma
Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma have?
Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma has 61 citations in the OpenAlex counts ScholarIQ stores.
When was Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma published?
Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma has 2016 year in the ScholarIQ index.
What is the open-access status of Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma?
Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma has closed oa status in the ScholarIQ index.
What is the DOI of Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma?
The DOI for Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma is on the source record.
What is the PMID of Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma?
The PMID for Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma is on the source record.
What is the OpenAlex record for Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma?
The OpenAlex for Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma is on the source record.